Ginsenosides | Cancer type | Effect | Mechanism |
20S-Rg3 | Gliomas | Reverse warburg effect and angiogenesis | Glycolysis pathway↓
HIF-1α↓
NKILA↓ |
20(S)-Rg3 | Ovarian cancer | Reverse warburg effect
Reduce DNA methylation | MiR-519a-5p↑
HIF-1α↓ |
Rg3 | Gastric precancerous lesions | Reverse Warburg effect | MiRNA-21↓
PI3K/Akt pathway↓ |
Rh4 | Esophageal cancer | Reverse Warburg effect | PD-L1↓
Akt/mTOR pathway↓ |
20(S)-Rh2E2 | Lewis lung cancer | Inhibit mitochondrial respiration and glycolysis
Inhibit tumor growth | α-enolase↓
Glycolytic enzymes↓
AMPK signaling↑
MAPK signaling↑ |
CK | Liver cancer | Reverse warburg effect
Inhibit tumor growth | HIF-1α↓
Bclaf1↓ |
G-Rh2 | Non-small cell lung cancer | Regulate FA metabolism
Improve immune deficiency
Synergistically inhibit tumor growth | PI3K/AKT pathway↓
SREBP↓
FASN↓ |
g-PPT | Non-small cell lung cancer | Inhibit lipid metabolism
Reverse the resistance to TKIs | LDs↓
SCD1↓ |
CK | Hepatocellular Carcinoma | Suppress lipid accumulation | AMPK↑
PPAR-α↑
CD36↑
FASN↓
SREBP1c↓
SCD1↓ |
PPD | Colorectal cancer | Modulate the metabolism of amino acids and lipids | AMPK↑
Sesn2↑
Autophagy↑ |
Rk1 | Hepatocellular carcinoma | Inhibit glutamine metabolism
Induce apoptosis
Inhibit tumor growth | ERK/c-myc pathway↓ |
CK | Breast cancer | Exert antitumor activity and trigger apoptosis
Suppress glutamine consumption | Amino acids associated with glutamine metabolism↓
GSH↓
ROS↑ |
Rb1, Rg1 | Colorectal cancer | Inhibit colorectal cancer cell growth
Induce apoptosis | Inhibit cellular3H-thymidine incorporation |
Rg3 | Breast cancer | Inhibit proliferation of breast cancer cells | NF-κB↓
Regulate protein synthesis and cell division |
G-Rh2 | Hepatocellular carcinoma | Induce apoptosis | Mitochondrial release of cytochrome c
Activation of caspase-3 |
Rd, Re | Human neuroblastoma | Inhibit apoptosis | Reduce oxidative stress
Improve mitochondrial integrity and functions |
GF2 | Glioblastoma | Induce cancer cell death | Reduce mitochondrial membrane potential
Inhibit cellular oxygen consumption Activate AMPK signaling |
CK | Lung cancer | Improve antitumor effect | Increase ROS level
Induce mitochondrial apoptosis |
Rh1 | Breast cancer | Favor mitophagy
Regulate ROS and mitochondrial autophagy | PINK↑
Parkin↑
PGC-1α↓ |
Rg2 | Breast cancer | Exert anti-cancer effects | Cell cycle arrest↑
ROS production↑ |
Rh4 | Colorectal cancer | Exert anti-cancer effects
Induce apoptosis and autophagic cell death | ROS/JNK/P53↑ |
Rh4 | Colorectal cancer | Inhibit tumor growth
Induce ferroptosis and autophagy | ROS/p53 signaling pathway↑ |
Rg3 | Lung cancer | Suppress lung cancer cell invasion | ROS↓
AKT/ERK↓
NF-κB↓
HIF1-α↓ |
Rg5 | Gastric cancer | Induce G2/M phase arrest, apoptosis and autophagy
Inhibit gastric cancer cells | ROS↑
MAPK pathway↑ |
Re | Neuroblastoma | Reduce oxidative stress
Alleviate 6-OHDA-induced neuronal damage | GPX4↑ |
Re | Lung cancer | Sensitize cancer cells to therapeutic drugs | NRF2 pathway↓ |
Rg3 | Colorectal cancer | Enhance the inhibition of colon cancer cell proliferation, migration and invasion
Promote apoptosis of colon cancer cells
Arrest the cells in the G0/G1 phase | PI3K/AKT pathway↓ |
Rh1 | Breast cancer | Inhibit migration, invasion, and angiogenesis | STAT3 and NF-κB signaling↓
ROS production↑ |
Rh2 | Cervical cancer | Inhibit cell viability
Induce apoptosis of cancer cells | ROS production↑
ATP synthesis↓
OXPHOS and glycolysis↓ |
Rh2 | Breast cancer | Reduce the toxic effect of senescent cells
Sustain the anti-tumor capacity of normal human breast epithelial cells | NF-κB↓
Mitophagy↑
ROS↓ |